Functionally, ZFPM2-AS1 insufficiency inhibited SCLC cell proliferation, invasion and migration in vitro and tumor growth in vivo, suggesting the carcinogenic role of ZFPM2-AS1 in SCLC. The gene discussed is ZFPM2; the disease is neoplasm.